久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Company Profile

Wuxi Taxus Pharmaceutical Co., Ltd.
Year Established : 2004
Total Assets(USD) : choose not to disclose
Total Number of Staff : 150 to 199
Main Competitive Advantages : Brandname,International Approvals/Standards,Experienced R&D Staff
  • Contact Person :
  • Fax:
Wuxi Taxus Pharmaceutical Co., Ltd is a High-Tech pharmaceutical enterprise with GMP and DMF. We are specially engaged in anticancer APIs, such as Paclitaxel(DMF:25759), Docetaxel, Cabazitaxel, Oxaliplatin, Irinotecan, Decitabine, Allopurinol, Ramosetron, Granisetron, Praziquantel,10-DAB,side chains and other anticancer Intermediates, APIs and Injections. Also we doing Custom-Synthesis and Toll manufacturing. Paclitaxel and Oxaliplatin registered in India, Korea etc.
PharmaSources Customer Service